Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India | Zendy

Vivekanandan Kalaiselvan | Zendy; Prasad Thota | Zendy; Abishank Singh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Current Status of Adverse Drug Reactions Monitoring Centres under Pharmacovigilance Programme of India

Author(s) -

Vivekanandan Kalaiselvan,

Prasad Thota,

Abishank Singh

Publication year - 2014

Publication title -

indian journal of pharmacy practice

Language(s) - English

Resource type - Journals

ISSN - 0974-8326

DOI - 10.5530/ijopp.7.3.5

Subject(s) - pharmacovigilance , medicine , adverse drug reaction , drug reaction , drug , adverse effect , intensive care medicine , pharmacology

There are one hundred and fifty Adverse Drug Reactions Monitoring Centres (AMCs) across the country are functioning and reporting’s Adverse Drug Reactions to National Coordination centre (NCC), Pharmacovigilance Programme of India (PvPI) at Indian Pharmacopoeia Commission (IPC), Ghaziabad. The AMCs are established to collate data on Pharmacovigilance and forward to NCC via online software (VigiFlow). The present AMCs are Medical Council of India (MCI) approved teaching hospitals and corporate hospitals. NCC is working with AMCs to coordinate with Pharmacy institutions to enhance ADRs reporting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research